Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-002778-35Phase 4Completed
Phase 4, open-label, single-arm trial of iohexol, sponsored by CHU de Limoges. Primary endpoint: Plasma and urinary iohexol concentration–time curves. Started Sep 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-002778-35.